TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Tedroff NeuroCare AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,543
|
14,560
|
11,918 |
Financial expenses |
2,513
|
1
|
1,635 |
Earnings before taxes |
3,266
|
7,140
|
3,177 |
EBITDA |
5,214
|
7,139
|
3,180 |
Total assets |
10,426
|
14,899
|
8,422 |
Current assets |
8,623
|
11,722
|
5,545 |
Current liabilities |
2,999
|
2,198
|
691 |
Equity capital |
4,579
|
12,464
|
7,494 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
5
![]() |
5
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
43.9%
|
83.7%
|
89.0% |
Turnover per employee |
3,309
|
2,912
|
3,973 |
Profit as a percentage of turnover |
19.7%
|
49.0%
|
26.7% |
Return on assets (ROA) |
55.4%
|
47.9%
|
57.1% |
Current ratio |
287.5%
|
533.3%
|
802.5% |
Return on equity (ROE) |
71.3%
|
57.3%
|
42.4% |
Change turnover |
1,983
|
2,642
|
-2,119 |
Change turnover % |
14%
|
22%
|
-15% |
Chg. No. of employees |
0
|
2
|
0 |
Chg. No. of employees % |
0%
|
67%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.